ASSOCIATION OF C - REACTIVE PROTEIN WITH PSYCHOTIC FEATURES IN POSTPARTUM DEPRESSION: A CROSS-SECTIONAL STUDY FROM PAKISTAN
Main Article Content
Keywords
Postpartum depression; psychotic features; C-reactive protein; inflammation; biomarker
Abstract
Background: Postpartum depression (PPD) is one of the commonest psychiatric disorders following childbirth. PPD may be complicated by psychotic features, substantially increasing maternal morbidity and mortality. Increasing evidence suggests that inflammatory processes contribute to affective and psychotic symptoms. C-reactive protein (CRP), a widely available inflammatory marker, has been implicated in the etiology of depressive disorders, yet data linking CRP with psychotic features in PPD remain limited, particularly from low- and middle-income countries like Pakistan.
Objectives: To study the correlation between serum C-reactive protein levels and psychotic symptoms among women with postpartum depression.
Methods: This cross-sectional study was carried out at a tertiary care hospital in Hyderabad, Pakistan, over six months. A total of 236 postpartum women were enrolled using non-probability consecutive sampling. Postpartum depression was evaluated using the Urdu version of the Edinburgh Postnatal Depression Scale (EPDS), while psychotic symptoms were assessed using the Brief Psychiatric Rating Scale (BPRS). Serum CRP levels were measured and categorized as normal (<5 mg/dL) or raised (≥5 mg/dL). Pearson correlation and logistic regression analyses were performed.
Results: The mean age of participants was 26.57 ± 5.87 years. Elevated CRP levels were observed in 47% of women. A significant positive correlation was found between CRP levels and psychotic symptom severity (r = 0.63, p < 0.05). Women with raised CRP had significantly higher odds of PPD with psychotic features (OR = 18.75; 95% CI: 9.68–36.30; p = 0.0005). After adjustment for sociodemographic and clinical variables, raised CRP remained an independent predictor (adjusted OR = 25.45; 95% CI: 11.76–55.06).
Conclusions: Elevated CRP levels are strongly associated with psychotic features in postpartum depression. These findings support the role of inflammation in the pathophysiology of severe postpartum mood disorders and highlight CRP as a potential biomarker for early identification of women at risk.
References
2. Shorey S, Chee CYI, Ng ED, Chan YH, Tam WWS, Chong YS. Prevalence and incidence of postpartum depression among healthy mothers: a systematic review and meta-analysis. J Psychiatr Res. 2018;104:235–48.
3. Stein A, Pearson RM, Goodman SH, et al. Effects of perinatal mental disorders on the fetus and child. Lancet. 2014;384(9956):1800–19.
4. Sit D, Rothschild AJ, Wisner KL. A review of postpartum psychosis. J Womens Health. 2006;15(4):352–68.
5. Brockington I. Postpartum psychiatric disorders. Lancet. 2004;363(9405):303–10.
6. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression. Nat Rev Neurosci. 2008;9(1):46–56.
7. Miller AH, Raison CL. The role of inflammation in depression. Nat Rev Immunol. 2016;16(1):22–34.
8. Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446–57.
9. Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients. Mol Psychiatry. 2016;21(12):1696–709.
10. Khandaker GM, Pearson RM, Zammit S, Lewis G, Jones PB. Association of serum interleukin-6 and CRP with depression. JAMA Psychiatry. 2014;71(10):1121–8.
11. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805–12.
12. Wium-Andersen MK, Ørsted DD, Nordestgaard BG. Elevated CRP and depression. Psychol Med. 2013;43(4):841–8.
13. Felger JC, Lotrich FE. Inflammatory cytokines in depression. Neuroscience. 2013;246:199–229.
14. Strawbridge R, Arnone D, Danese A, Papadopoulos A, Herane Vives A, Cleare AJ. Inflammation and clinical response to treatment. Brain Behav Immun. 2015;49:17–24.
15. Groer MW, Morgan K. Immune, health and endocrine characteristics of depressed postpartum mothers. Psychoneuroendocrinology. 2007;32(2):133–9.
16. Corwin EJ, Pajer K, Paul S, et al. Bidirectional psychoneuroimmune interactions in postpartum women. Brain Behav Immun. 2015;49:86–97.
17. Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR. Effects of gonadal steroids on mood. Am J Psychiatry. 2000;157(6):924–30.
18. Maes M, Ombelet W, De Jongh R, Kenis G, Bosmans E. The immune-inflammatory pathophysiology of pregnancy and postpartum depression. Psychoneuroendocrinology. 2001;26(7):665–89.
19. Anderson G, Maes M. Postpartum depression: psychoneuroimmunological underpinnings. Neuropsychiatr Dis Treat. 2013;9:277–87.
20. Bergink V, Rasgon N, Wisner KL. Postpartum psychosis. Am J Psychiatry. 2016;173(12):1179–88.
21. Liu X, Agerbo E, Li J, et al. C-reactive protein and postpartum depression. Brain Behav Immun. 2016;55:136–4

